Skip to content
About
Clinical Trials
Resources
Contact
Menu
About
Clinical Trials
Resources
Contact
ARTIST
A phase II, open -label, multi-center, basket study of the ATR kinase inhibitor ART0380 administered orally as monotherapy to patients with biologically selected advanced or metastatic solid tumors
Status:
Open
Trial Type:
Early Phase Trials for Multiple Cancer Types
Contact:
Dr. Cara Mathews
cmathews@wihri.org